valproic acid has been researched along with alprazolam in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Biggio, G; Concas, A; Mascia, MP; Sanna, E; Santoro, V; Serra, M | 1 |
| Altamura, AC; Mauri, MC; Percudani, M; Regazzetti, MG | 1 |
| Malcolm, R; Roberts, JM; Santos, AB | 1 |
| Jefferson, JW | 1 |
| Endo, T; Kawamura, S; Maruta, M; Sakai, A | 1 |
| Aalouane, R; Barrimi, M; Hlal, H; Kettani, N; Rammouz, I | 1 |
| Aragão, I; Cardoso, T; Guedes, F; Maia, JM | 1 |
2 review(s) available for valproic acid and alprazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alternative prophylactic treatments to lithium in bipolar disorders.
Topics: Alprazolam; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clonazepam; Humans; Lithium; Valproic Acid | 1990 |
13 other study(ies) available for valproic acid and alprazolam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
"Ex vivo" binding of 35S-TBPS as a tool to study the pharmacology of GABAA receptors.
Topics: Alprazolam; Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Convulsants; Diazepam; Drug Synergism; Ethanol; In Vitro Techniques; Isoniazid; Male; Protein Conformation; Rats; Rats, Inbred Strains; Receptors, GABA-A; Stress, Physiological; Sulfur Radioisotopes; Valproic Acid | 1990 |
Treatment of panic disorder and comorbid substance abuse with divalproex sodium.
Topics: Adult; Alprazolam; Comorbidity; Humans; Male; Panic Disorder; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 1994 |
Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder).
Topics: Acetates; Alprazolam; Amines; Anticonvulsants; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Cyclohexanecarboxylic Acids; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Phobic Disorders; Placebos; Pregabalin; Treatment Outcome; Valproic Acid | 2001 |
Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive.
Topics: Adult; Alprazolam; Borderline Personality Disorder; Calcium Channel Blockers; Contraceptives, Oral, Combined; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Mestranol; Migraine with Aura; Norethindrone; Piperazines; Suicide, Attempted; Valproic Acid | 2008 |
["Factitious disorder and skin picking: Clinical approach". A case report].
Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Factitious Disorders; Female; Humans; Hypochondriasis; Self-Injurious Behavior; Skin; Somatoform Disorders; Valproic Acid; Young Adult | 2014 |
Eosinophilic pneumonia presenting as life-threatening ARDS.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Caustics; Cough; Drug Therapy, Combination; Eosinophilia; Eosinophils; Female; Glucocorticoids; Humans; Lye; Paroxetine; Prednisone; Pulmonary Eosinophilia; Radiography, Thoracic; Respiratory Distress Syndrome; Suicide, Attempted; Treatment Outcome; Valproic Acid | 2015 |